Pulse Therapeutics Inc, based in Saint Louis, MO, is a pioneering medical device company that has developed the Pulse NanoMED System, a groundbreaking nanoscale interventional tool designed to treat complex vascular occlusions that are unreachable with existing treatments. The system utilizes iron-oxide nanoparticles that, under the influence of an external rotating magnet, can disrupt distal vessel occlusions, providing a solution for conditions such as acute ischemic stroke, ST-elevation myocardial infarction (STEMI), and peripheral arterial disease (PAD).
With a focus on achieving Total Tissue Reperfusion (TTR) and restoring life-saving blood flow, Pulse Therapeutics aims to revolutionize the treatment of vascular occlusions. Their innovative technology extends beyond the reach of wires and catheters, allowing for more comprehensive reperfusion and better patient outcomes. By addressing challenging areas and navigating smaller, more tortuous arteries, the Pulse NanoMED System offers a disruptive and life-saving solution, improving health economics and potentially saving lives.
Generated from the website